British researchers show today how a newly-discovered “ultrabad” form of cholesterol increases the risk of heart disease.
Researchers at the University of Warwick, England, found that MGmin-low-density lipoprotein (LDL), which is more common in people with type 2 diabetes and the elderly, appears to be stickier than normal LDL.
It means that it is easier to attach to the walls of arteries and form s dangerous “fatty” plaques’ that cause coronary heart disease.
The finding, published in the journal Diabetes, could lead to new treatments that would prevent heart disease in the elderly and in those with type 2 diabetes.
The researchers found that MGmin-LDL is created when sugar groups are added to “normal” LDL, which makes it smaller and denser.
The sugar groups expose new regions on the surface of the LDL, which are more likely to stick to artery walls and build fatty plaques.
As these grow, they narrow the arteries, thereby reducing blood flow, which can eventually rupture, triggering a blood clot that causes a heart attack or stroke.
Dr Naila Rabbani, who led the British Heart Foundation-funded study, said: “We’re excited to see our research leading to a greater understanding of this type of cholesterol, which seems to help cause heart disease in diabetics and elderly people.
“The next challenge is to tackle this more dangerous type of cholesterol with treatments that could help neutralise its harmful effects on patients’ arteries.”
Dr Shannon Amoils, research adviser at the BHF, said: “Understanding exactly how ‘ultrabad’ LDL damages arteries is crucial, as this knowledge could help develop new anti-cholesterol treatments for patients.”
Glycation of low density lipoprotein by methylglyoxal increases atherogenicity – a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes May 27 2011 doi: 10.2337/db11-0085

Leave a Reply